Cullinan Associates’s Equifax EFX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$765K Hold
4,250
0.06% 131
2025
Q4
$922K Hold
4,250
0.06% 134
2025
Q3
$1.09M Hold
4,250
0.07% 130
2025
Q2
$1.1M Hold
4,250
0.07% 125
2025
Q1
$1.04M Hold
4,250
0.07% 127
2024
Q4
$1.08M Hold
4,250
0.07% 131
2024
Q3
$1.17M Sell
4,250
-315
-7% -$88.8K 0.07% 130
2024
Q2
$1.11M Sell
4,565
-185
-4% -$44.1K 0.06% 139
2024
Q1
$1.27M Sell
4,750
-250
-5% -$63.6K 0.07% 139
2023
Q4
$1.24M Buy
+5,000
New +$1.01M 0.07% 136

Other funds holding EFX

Cullinan Associates's EFX Position: Q1 2026 in Review

Cullinan Associates held its Equifax (EFX) position steady in Q1 2026 at 4,250 shares worth $765K. The position accounts for 0.06% of the portfolio, ranked #131.

Cullinan Associates first reported a position in EFX in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.27M in Q1 2024. 870 funds tracked by Wall St. Rank hold EFX as of Q1 2026.

  • Cullinan Associates held 4,250 shares of Equifax worth $765K as of Q1 2026.
  • Cullinan Associates left its Equifax share count unchanged in Q1 2026.
  • Equifax made up 0.06% of Cullinan Associates's portfolio in Q1 2026, its #131 holding.
  • Cullinan Associates first reported a position in Equifax in Q4 2023 and has held it in 10 quarters since.
  • Cullinan Associates's Equifax position peaked at $1.27M in Q1 2024.
  • 870 funds tracked by Wall St. Rank held Equifax as of Q1 2026.

Based on Cullinan Associates's 13F filing for Q1 2026, filed 1 May 2026.